Inventaire - your friends and communities are your best library

Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties

Author

Peggy Farnham

Published in: Cell

Date of publication: July 24, 1992

Language: English

Main subject: retinoblastoma, intracellular signaling peptides and proteins, cell cycle proteins, tumor suppressor proteins

Bibliographic databases:

Cites articles 58

Date

Title

Authors

July 1977

Characteristics of a human cell line transformed by DNA from human adenovirus type 5
September 1, 1981

Monoclonal antibodies specific for simian virus 40 tumor antigens
September 1, 1985

Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products
January 1, 1986

Phosphorylation of human immune interferon (IFN-gamma)
August 29, 1986

A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation
October 1, 1987

Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells
January 1, 1987

Rapid site-specific mutagenesis in plasmids
April 1, 1987

Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control
June 19, 1987

Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements
July 15, 1988

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
December 1, 1988

Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells
January 1, 1988

Activation of a preexisting cellular factor as a basis for adenovirus E1A-mediated transcription control
September 1, 1988

The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells
July 15, 1988

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase
June 1, 1989

Phosphorylation-dependent activation of the adenovirus-inducible E2F transcription factor in a cell-free system
April 14, 1989

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas
November 1, 1989

Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo
September 1, 1989

The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element
November 1, 1989

The adenovirus early region 4 open reading frame 6/7 protein regulates the DNA binding activity of the cellular transcription factor, E2F, through a direct complex
January 1, 1989

SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family
August 1, 1989

Structure and partial genomic sequence of the human retinoblastoma susceptibility gene
July 28, 1989

Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins
March 10, 1989

A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins
January 1, 1989

Synchronous and sequential activation of latently infected Epstein-Barr virus genomes
February 1, 1989

The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding
February 1, 1990

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.
November 1, 1990

cdc2 gene expression at the G1 to S transition in human T lymphocytes
April 1, 1990

Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells
July 1990

Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product
September 1, 1990

A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding
May 1, 1990

How different eukaryotic transcriptional activators can cooperate promiscuously
February 1, 1990

The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T.

Article -

Welcome to inventaire

The library of your friends and communities

Learn more